The natural modulation of the amplification phase of complement activation
- PMID: 62426
- DOI: 10.1111/j.1600-065x.1976.tb00226.x
The natural modulation of the amplification phase of complement activation
Abstract
As C3 cleavage represents the most critical step in the elaboration of the biologic effects of the complement system, the modulation of this reaction by formation and function of the C3b-dependent C3 convertase may well determine whether the initial activation of the complement sequence eventuates in beneficial or detrimental effects to the host. Stabilization of the amplification C3b-dependent convertase, C3bBb, is achieved with P and C3NeF, respectively, after their binding which exhibits different molecular and temperature requirements. Control of this amplifying step occurs at three levels: intrinsic decay of the inherently labile C3bBb convertase; extrinsic decay by displacement of Bb from the convertase with beta1H; and inactivation by C3bINA of C3b after its generation from native C3 or removal of protective Bb by intrinsic or extrinsic decay. In the presence of the stabilizing factors the control proteins must function in sequence with beta1H-mediated decay preceding C3b inactivation.
Similar articles
-
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review.
-
Control of the amplification convertase of complement by the plasma protein beta1H.Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72. doi: 10.1073/pnas.73.9.3268. Proc Natl Acad Sci U S A. 1976. PMID: 1067618 Free PMC article.
-
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076. J Exp Med. 1976. PMID: 978134 Free PMC article.
-
Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.J Exp Med. 1977 Jul 1;146(1):22-33. doi: 10.1084/jem.146.1.22. J Exp Med. 1977. PMID: 559720 Free PMC article.
-
A molecular basis of activation of the alternative pathway of human complement.Adv Exp Med Biol. 1979;120B:3-17. Adv Exp Med Biol. 1979. PMID: 390986 Review.
Cited by
-
Meningococcal infection and proteolytic control.J Clin Pathol. 1978 Dec;31(12):1177-81. doi: 10.1136/jcp.31.12.1177. J Clin Pathol. 1978. PMID: 85637 Free PMC article.
-
Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).Front Immunol. 2019 May 7;10:885. doi: 10.3389/fimmu.2019.00885. eCollection 2019. Front Immunol. 2019. PMID: 31134052 Free PMC article.
-
Immunological, structural and functional relationships between an anti-complementary protein from Crotalus atrox venom, cobra venom factor and human C3.Immunology. 1980 Apr;39(4):503-9. Immunology. 1980. PMID: 6769786 Free PMC article.
-
An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.J Am Soc Nephrol. 2018 Jun;29(6):1649-1661. doi: 10.1681/ASN.2017091006. Epub 2018 Mar 27. J Am Soc Nephrol. 2018. PMID: 29588430 Free PMC article.
-
Complement activation in asymptomatic patients with sickle cell anaemia.Clin Exp Immunol. 1979 Apr;36(1):130-9. Clin Exp Immunol. 1979. PMID: 466858 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous